- Male or female subjects 18 years of age with type 1 or type 2 diabetes.
- Subjects with peripheral occlusive arterial disease (PAOD) and a neuropathy
disability score (NDS) of >3
- Subjects who have undergone vascular reconstruction or angioplasty less than 1 month
prior to randomization. Subjects with an ulcer grading of 0 or 3 and staging of A, B
or D according to the University of Texas wound classification system.
- Subjects with a known bleeding disorder or evidence of active bleeding.